Antifungal type 1 responses are upregulated in IL-10-deficient mice

Microbes and Infection

Volumn 1, Issue 14, 1999, Pages 1169-1180

  Del Sero, Giuseppe ^a   Mencacci, Antonella ^a   Cenci, Elio ^a   Fè D'Ostiani, Cristiana ^a   Montagnoli, Claudia ^a   Bacci, Angela ^a   Mosci, Paolo ^a   Kopf, Manfred ^b   Romani, Luigina ^a  

^a Microbiology Section   (Italy)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

Cytokines; Fungi; Knockout mice; Th1 Th2 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FEMALE; GENETIC SUSCEPTIBILITY; HELPER CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INFLAMMATION; KNOCKOUT MOUSE; LUNG ASPERGILLOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032786996     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00245-2     Document Type: Article

References (81)

1. Armstrong D. Overview of invasive fungal infections and clinical presentation, Baillières. Clin. Infect. Dis. 2:1995;17-24.
2. Saral R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13:1991;487-492.
3. Anaissie E.J. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14 S (Suppl 1):1992;43-53.
4. Denning D.W. Invasive Aspergillosis. Clin. Infect. Dis. 26:1998;781-805.
5. Walsh T.J., Whitcomb P.O., Revankar S.G., Pizzo P.A. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer. 76:1995;2357-2362.
6. Denning D.W., Follansbee S.E., Scolaro M., Norris S., Edelstein H., Stevens D.A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. M. 324:1991;654-662.
7. Powderly W.G. Broder S.M, Merigan Jr T.C, Bolognesi D. Textbook of AIDS Medicine. 1994;345-367 Williams & Wilkins, Baltimore.
8. Girmenia C., Martino P., Cassone A. Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies. Blood. 87:1996;838-839.
9. Roilides E., Pizzo P.A. Modulation of host defences by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:1992;508-524.
10. Kullberg B.J. Trends in immunotherapy of fungal infections. Eur. J. Clin. Microbiol. Infect. Dis. 16:1997;51-55.
11. Stevens D.A. Combination immunotherapy and antifungal chemotherapy. Clin. Infect. Dis. 26:1998;1266-1269.
12. Mencacci A., Cenci E., Bistoni F., Bacci A., DelSero G., Montagnoli C., Fè D'Ostiani C., Romani L. Specific and nonspecific immunity to Candida albicans: a lesson from genetically modified animals. Res. Immunol. 149:1998;352-361.
13. Cenci E., Mencacci A., Fè D'Ostiani C., Montagnoli C., Bacci A., Del Sero G., Perito S., Bistoni F., Romani L. Cytokine- and T-helper-dependent immunity in murine aspergillosis. Res. Immunol. 149:1998;445-454.
14. Puccetti P., Romani L., Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:1995;237-240.
15. Fidel P.L. Jr, Sobel J.D. The role of cell-mediated immunity in candidiasis. Trends Microbiol. 6:1994;202-206.
16. Grazziutti M.L., Rex J.H., Cowart E.R., Anaissie E.J., Ford A., Savary C.A. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J. Infect. Dis. 176:1998;1579-1583.
17. Wolach B., Alon E., Gottesman G., Yellin A. Pulmonary aspergillosis in a child with hyperimmunoglobulin E syndrome. J. Infect. Dis. 26:1998;204-205.
18. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59:1991;4647-4654.
19. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:1993;925-931.
20. Cenci E., Perito S., Enssle K.H., Mosci P., Latgè J.P., Romani L., Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 65:1997;564-570.
21. Cenci E., Mencacci A., Fe'D'Ostiani C., DelSero G., Mosci P., Montagnoli C., Bacci A., Romani L. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J. Infect. Dis. 178:1998;1750-1760.
22. Romani L. The T cell response against fungal infections. Curr. Opin. Immunol. 9:1997;484-490.
23. Moore K.W., O' Garra A., De Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Ann. Rev. Immunol. 11:1993;165-190.
24. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an α T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:1992;6065-6069.
25. Ding L., Shevach E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectivey inhibiting macrophage costimulatory function. J. Immunol. 148:1992;3133-3139.
26. Ding L., Linsley P.S., Huang L.Y., Germain R.N., Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1993;1224-1234.
27. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1991;3444-3451.
28. Gazzinelli R.T., Oswald I.P., James S.L., Sher A. IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J. Immunol. 148:1992;1792-1796.
29. Romani L., Puccetti P., Mencacci A., Cenci E., Spaccapelo R., Tonnetti L., Grohmann U., Bistoni F. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans, J. Immunol. 152:1994;3514-3521.
30. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23:1993;1034-1038.
31. Levitz S., Tabuni A., Nong S.H., Golenbock D.T. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans and lipopolysaccharide. Infect. Immun. 64:1996;945-951.
32. Roilides E., Dimitriadou A., Kadiltsoglou I., Sein T., Karpouzas J., Pizzo P.A., Walsh T.J. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol. 158:1997;322-329.
33. Roilides E., Anastasiou-Katsiardani A., Dimitriadou-Georgiadou A., Kadiltsoglou I., Tsaparidou S., Panteliadis C., Walsh T.J. Suppressive effects of interleukin-10 on human mononuclear phagocytic function against Candida albicans and Staphylococcus aureus. J. Infect. Dis. 178:1998;1734-1742.
34. Vecchiarelli A., Retini C., Monari C., Tascini C., Bistoni F., Kozel T.R. Purified capsular polysaccaride of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:1996;2846-2849.
35. Tonnetti L., Spaccapelo R., Cenci E., Mencacci A., Puccetti P., Coffman R.L., Bistoni F., Romani L. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25:1995;1559-1565.
36. Vazquez-Torres A., Jones-Carson J., Wagner R.D., Warner T., Balish E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 67:1999;670-674.
37. Roilides E., Sein T., Schaufele R., Chanock S.J., Walsh T.J. Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J. Infect. Dis. 178:1998;589-592.
38. Kaposzta R., Tree P., Marodi L., Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun. 66:1998;1708-1717.
39. Qian Q., Cutler J.E. Gamma-interferon is not essential in host defense against disseminated candidiasis in mice. Infect. Immun. 65:1997;1748-1753.
40. Romani L., Mencacci A., Grohmann U., Mocci S., Mosci P., Puccetti P., Bistoni F. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. M. 176:1992;19-25.
41. Cenci E., Mencacci A., DelSero G., Fè D'Ostiani C., Bacci A., Montagnoli C., Kopf M., Romani L. IFN-γ is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 161:1998;3543-3550.
42. Grünig G., Corry D.B., Leach M.V., Seymour B.W.P., Kurup V.P., Rennick B.M. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. M. 185:1997;1089-1099.
43. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
44. Cenci E., Mencacci A., Spaccapelo R., Tonnetti L., Enssle K.H., Puccetti P., Romani L., Bistoni F. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1995;1279-1288.
45. Griffiths M.J., Messent M., Macallister R.J., Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110:1993;963-968.
46. + T helper subset selection in mice with candidiasis. J. Immunol. 158:1997;2356-2362.
47. Romani L., Mencacci A., Cenci E., Spaccapelo R., DelSero G., Nicoletti I., Trinchieri G., Bistoni F., Puccetti P. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:1997;5349-5356.
48. Reiner S.L., Zheng S., Corry D.B., Locksley R.M. Constructing polycompetitor cDNA for quantitative PCR. J. Immunol. Methods. 165:1993;37-46.
49. Romani L., Bistoni F., Puccetti P. Initiation of T-helper cell immunity to Candida albicans: the role of neutrophils. Chem. Immunol. 68:1997;110-135.
50. Mencacci A., Cenci E., DelSero G., Fè D'Ostiani C., Mosci P., Montagnoli C., Bacci A., Bistoni F., Quesniaux V.F.J., Ryffel B., Romani L. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-α double-deficient mice infected with Candida albicans. Int. Immunol. 10:1998;37-48.
51. Jones-Carson J., Vazquez-Torres A., Van DerHeyde H.C., Warner T., Wagner R.D., Balish E. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. M. 6:1995;552-557.
52. Vazquez-Torres A., Jones-Carson J., Warner T., Balish E. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. 172:1995;192-198.
53. Romani L., Bistoni F., Mencacci A., Cenci E., Spaccapelo R., Puccetti P. IL12 in Candida albicans infections. Res. Immunol. 146:1996;532-538.
54. Dai W., Kohler G., Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158:1997;2259-2267.
55. Yang X., Gartner J., Zhu L., Wang S., Brunham R.C. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162:1999;1010-1017.
56. + T cells accompanied by overproduction of IL-12, IFN-γ, and TNF-α J. Immunol. 157:1996;798-805.
57. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. M. 177:1993;1205-1208.
58. Florquin S., Amraoui Z., Abramowicz D., Goldman M. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:1994;2618-2623.
59. + T helper type 1 cell responses to Candida albicans. J. Immunol. 161:1998;6228-6237.
60. + TH1-like responses. J. Clin. Invest. 98:1996;1010-1020.
61. Kullberg M.C., Ward J.M., Gorelick P.L., Caspar P., Hieny S., Cheever A., Jankovic D., Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66:1998;5157-5166.
62. Rementeria A., Garcia-Tobalina R., Sevilla M.J. Nitric oxide-dependent killing of Candida albicans by murine peritoneal cells during an experimental infection. FEMS Immunol. Med. Microbiol. 11:1995;157-162.
63. Bogdan C. The multiplex function of nitric oxide in (auto) immunity. J. Exp. M. 187:1998;1361-1365.
64. Vazquez-Torres A., Jones-Carson J., Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63:1995;1142-1144.
65. Kobayashi S.D., Cutler J.E. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol. 6:1998;92-94.
66. Hogaboam C.M., Chensue S.W., Steinhauser M.L., Huffnagle G.B., Lukacs N.W., Strieter R.M., Kunkel S.L. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J. Immunol. 159:1997;5585-5593.
67. Goldman D., Cho Y., Zhao M.L., Casadevall A., Lee S.C. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. Am. J. Pathol. 148:1996;1275-1282.
68. Michaliszyn E., Senechal S., Martel P., DeRepentigny L. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect. Immun. 63:1995;2075-2078.
69. Greenberger M.J., Strieter R.M., Kunkel S.L., Danforth J.M., Goodman R.E., Standiford T.J. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:1995;722-729.
70. Sawa T., Corry D.B., Gropper M.A., Ohara M., Kurahashi K., Wiener-Kronish J.P. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 159:1997;2858-2866.
71. Van der Poll T., Marchant A., Keogh C.V., Goldman M., Lowry S.F. IL-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:1996;994-1000.
72. Steinhauser M.L., Hogaboam C.M., Kunkel S.L., Lukacs N.W., Strieter R.M., Standiford T.J. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162:1999;392-399.
73. Huffnagle G.B., Lipscomb M.F. Cells and cytokines in pulmonary cryptococcosis. Res. Immunol. 149:1998;387-396.
74. Zuany-Amorim C., Haile S., Leduc D., Dumarey C., Huerre M., Vargaftig B.B., Pretolani M. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95:1995;2644-2651.
75. Roilides E., Katsifa H., Walsh T.J. Pulmonary host defences against Aspergillus fumigatus. Res. Immunol. 149:1998;454-465.
76. Mencacci A., Cenci E., Boelaert J.R., Bucci P., Mosci P., Fè D'Ostiani C., Bistoni F., Romani L. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J. Infect. Dis. 175:1997;1467-1476.
77. Rennick D.M., Fort M.M., Davidson N.J. Studies with IL-10-/- mice: an overview. J. Leukoc. Biol. 61:1997;389-396.
78. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. M. 184:1996;241-251.
79. Sartor R.B. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can. J. Gastroenterol. 4:1990;271-277.
80. Odds F.C. Candida and Candidosis, 2nd. 1988;68-92 Baillière Tindall, London. in.
81. Marchant A., Deviere J., Byl B., DeGroote D., Vincent J.L., Goldman M. Interleukin-10 production during septicemia. Lancet. 343:1994;707-708.